These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11778847)
1. Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat. Barthwal MK; Srivastava N; Dikshit M Redox Rep; 2001; 6(5):297-302. PubMed ID: 11778847 [TBL] [Abstract][Full Text] [Related]
2. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Srinivasan J; Schmidt WJ Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435 [TBL] [Abstract][Full Text] [Related]
3. Nitric oxide regulates NMDA-induced dopamine release in rat striatum. Shibata M; Araki N; Ohta K; Hamada J; Shimazu K; Fukuuchi Y Neuroreport; 1996 Jan; 7(2):605-8. PubMed ID: 8730840 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine. Taraska T; Finnegan KT J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310 [TBL] [Abstract][Full Text] [Related]
5. L-arginine produces NO-independent increases in dopamine efflux in rat striatum. Silva MT; Rose S; Hindmarsh JG; Jenner P; Marsden CD Neuroreport; 1998 Jan; 9(1):149-52. PubMed ID: 9592066 [TBL] [Abstract][Full Text] [Related]
6. Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum. Faro LR; Ferreira Nunes BV; Alfonso M; Ferreira VM; Durán R Toxicology; 2013 Sep; 311(3):154-61. PubMed ID: 23810826 [TBL] [Abstract][Full Text] [Related]
7. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation. Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727 [TBL] [Abstract][Full Text] [Related]
8. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease. Lin L; Meng T; Liu T; Zheng Z Life Sci; 2013 Mar; 92(4-5):311-6. PubMed ID: 23333823 [TBL] [Abstract][Full Text] [Related]
9. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway. Gomes MZ; Raisman-Vozari R; Del Bel EA Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645 [TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA. Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568 [TBL] [Abstract][Full Text] [Related]
11. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944 [TBL] [Abstract][Full Text] [Related]
12. A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum. Kiss JP; Hennings EC; Zsilla G; Vizi ES Neurochem Int; 1999 Apr; 34(4):345-50. PubMed ID: 10372921 [TBL] [Abstract][Full Text] [Related]
13. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions. Han B; Jin HJ; Song MY; Wang T; Zhao H Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971 [TBL] [Abstract][Full Text] [Related]
14. Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study . Di Matteo V; Pierucci M; Benigno A; Crescimanno G; Esposito E; Di Giovanni G Ann N Y Acad Sci; 2009 Feb; 1155():309-15. PubMed ID: 19250222 [TBL] [Abstract][Full Text] [Related]
15. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Joniec I; Ciesielska A; Kurkowska-Jastrzebska I; Przybylkowski A; Czlonkowska A; Czlonkowski A Brain Res; 2009 Mar; 1261():7-19. PubMed ID: 19401171 [TBL] [Abstract][Full Text] [Related]
16. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats. Wei CL; Hon WM; Lee KH; Khoo HE Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502 [TBL] [Abstract][Full Text] [Related]
17. The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats. Czarnecka A; Konieczny J; Lenda T; Lorenc-Koci E Brain Res; 2015 Nov; 1625():218-37. PubMed ID: 26319690 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Koeberle PD; Ball AK Exp Neurol; 1999 Aug; 158(2):366-81. PubMed ID: 10415143 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide alterations in cardiovascular system of rats with Parkinsonism induced by 6-OHDA and submitted to previous exercise. de Jager L; Amorim EDT; Lucchetti BFC; Lopes FNC; Crestani CC; Pinge-Filho P; Martins-Pinge MC Life Sci; 2018 Jul; 204():78-86. PubMed ID: 29746848 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide. Singh S; Kumar S; Dikshit M Redox Rep; 2010; 15(3):115-22. PubMed ID: 20594414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]